NCT03923504 Improving Exercise Capacity With Tailored Physical Activity in Lymphoma & Breast Cancer Patients Undergoing Tx Status COMPLETED Phase NA
NCT03921879 Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma Status UNKNOWN Phase PHASE1
NCT03919175 Umbralisib and Rituximab as Initial Therapy for Patients With Follicular Lymphoma and Marginal Zone Lymphoma Status TERMINATED Phase PHASE2
NCT03884556 TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers Status COMPLETED Phase PHASE1
NCT03856216 Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation Status TERMINATED Phase PHASE2
NCT03852823 Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours Status UNKNOWN Phase PHASE1
NCT03850171 Cancer Adverse Effects PReventIon With Care & Exercise: the CAPRICE Study Status TERMINATED Phase NA
NCT03849950 Self-Management and Activation to Reduce Treatment-Related Toxicities (SMARTCare) Status TERMINATED Phase NA
NCT03841110 FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT03836690 Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation Status UNKNOWN Phase PHASE1
NCT03834584 A Study of AG-636 in the Treatment of Subjects With Advanced Lymphoma Status TERMINATED Phase PHASE1
NCT03829254 A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma Status RECRUITING Phase PHASE1/PHASE2
NCT03823534 Post-Op Pain Control for Prophylactic Intramedullary Nailing. Status RECRUITING Phase PHASE3
NCT03815682 RPTR-147 in Patients With Selected Solid Tumors and Lymphomas Status TERMINATED Phase PHASE1
NCT03809767 A Study of CS1003 in Subjects With Advanced Solid Tumors or Lymphomas Status COMPLETED Phase PHASE1
NCT03794635 An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT03793140 A Study of CPI-613 for Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma With High-Risk Translocations Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03786926 Trial to Evaluate the Safety and Pharmacokinetics of HMPL-689 in Patients With Lymphomas Status TERMINATED Phase PHASE1